t’s been about six years since San Diego’s Epic Sciences was founded to commercialize technology that Peter Kuhn and others developed at The Scripps Research Institute for detecting and analyzing circulating tumor cells.
In more recent years, the company has moved rapidly to create an entirely new business based on its diagnostic technology. Epic Sciences says it has established about 30 partnerships and research collaborations with both pharmaceutical companies and academic scientists, and its technology is being used to analyze many types of cancer in thousands of patients. Over the past year, the company’s workforce has doubled, from 30 to about 60 employees.
When Amanda Boxtel, executive director of the Bridging Bionics Foundation, crushed her vertebrae in a skiing accident 22 years ago, she had to get used to life permanently confined in a wheelchair.
Gur Bittan envisions a future where you’re not just capturing a regular video of a child’s first steps with a smartphone; you’re doing it in 3-D, and sharing it with friends who can manipulate the video to watch it from different perspectives—even the kid’s point of view, providing you’ve scanned the scene from enough angles.
Bittan is the chief technology officer of Mantis Vision, an Israel-based 3-D technology company that hopes to make this kind of experience commonplace. If its 3-D technology is included in mobile gadgets like smartphones and tablets, it could make something as simple as communicating with friends more immersive.
Electric vehicle sales in Europe doubled again in 2013 for the fourth consecutive year, with more than one in every 20 new auto-buyers in the Netherlands and Norway opting for battery-powered cars, according to analysis of official data by the Transport and Environment (T&E) environmental think tank.
The paper found that 50,000 plug-in vehicles were sold across the EU in 2013 – 0.4% of all car sales – with the market set to grow to 100,000 vehicles by 2015, 500,000 by 2021 and 1 million by 2025, if the trend continues.
Nano-sized devices and robots that could be deployed inside the body to deliver medicine or clear out cholesterol would make medical treatment faster and more effective. The challenge is to deliver the devices to the right spot in the body. That would require a nano-sized propulsion system — and now that’s in the realm of the possible.
Researchers from the Technion and from two German institutions have come up with a nano-sized propeller that could, when attached to a device, make its way through the viscous materials that make up the human body, like blood and fat.
The biodesign innovation process has been developed to help medical technology innovators increase their likelihood of success in identifying important clinical needs, inventing new medical devices and instruments, and implementing these advances in patient care. This approach is described in detail in the book Biodesign: The Process of Innovating Medical Technologies.
This website is a companion to the text, designed to provide innovators with active web links to support the Getting Started sections at the end of each chapter, relevant content updates, short videos of experts in the field, and links to other useful resources as they apply the biodesign process to projects in industry or academia. Use the menu on the left to access these materials by chapter.
La alianza empresarial impulsará las capacidades de ingeniería y gestión de proyectos de alta complejidad de Fiansa, y permitirá a Urssa acceder a nuevos proyectos en Perú y en mercados limítrofes.
Fiansa, especialista en obras metalmecánicas de la corporación peruana Ferreycorp, y URSSA, empresa especializada en construcciones metálicas e integrada en MONDRAGON, celebraron su asociación reciente en un concurrido evento que tuvo lugar en Lima (Perú).
As the Internet of Things (IoT) spreads, the implications for business model innovation are huge. Filling out well-known frameworks and streamlining established business models won’t be enough. To take advantage of new, cloud-based opportunities, today’s companies will need to fundamentally rethink their orthodoxies about value creation and value capture.
Over the last decade, we have seen a shift in the types of information that fuel business decisions making. There has been a transition from basing decisions and knowledge on limited qualitative and quantitative research to the development of a more comprehensive, real-time decision making process that utilizes today’s increased information flow. Company statements, online marketplaces, social media, intellectual property registries, and academic publications just a few examples of publicly available sources of information that hold potentially game-changing value to business leaders. But how do we see this shift playing out in how actual decisions are made?
Informe elaborado por el Boston Consulting Group (BCG) con motivo del 50º aniversario de la creación de la firma a nivel mundial y el 25ª aniversario de su presencia en España, en colaboración con el Ministerio de Industria,Energía y Turismo (MINETUR).
